Insulet

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 1
Rounds per year 0.10
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Key employees Soon

Areas of investment

  • mHealth
  • Software
  • Diabetes
  • Health Care
  • Mobile Apps
Summary

In 2000 was created Insulet, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Bedford. The fund was located in North America if to be more exact in United States.

The top activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Glooko. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Software, Mobile Apps.

The usual cause for the fund is to invest in rounds with 7 partakers. Despite the Insulet, startups are often financed by Social Capital, Samsung NEXT, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Social Capital, Samsung NEXT, Medtronic.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Insulet:
Typical Co-investors
Insulet is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Insulet:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
14th Street Global Ventures -
Billiken Angels Network Missouri, St Louis, United States
Covidien County Dublin, Dublin, Ireland
CPMG Dallas, Texas, United States
Ernst Gohner Stiftung Cham, Switzerland, Zug
Hangzhou Lianchuang Investment China, Hangzhou, Zhejiang
IPV Capital China, Shanghai
Kokusai Kogyo Japan, Tokyo
Life Science Venture Capital Management -
MCM Investment Partners -
Navare Invest -
Neu Venture Capital New York, New York, United States
Patagonia Ventures Argentina, Buenos Aires, Distrito Federal
SKS Capital California, Los Altos Hills, United States
Start-Up Brasil Brazil, São Paulo, Sao Paulo
Startupbootcamp Fintech New York New York, New York, United States
Surya Ventures Pte Ltd Central, Central Region, Singapore
UJ Ventures California, Los Altos, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Glooko

Diabetes
Health Care
mHealth
Mobile Apps
Software
$30M16 Mar 2021 Mountain View, California, United States

Glooko

Diabetes
Health Care
mHealth
Mobile Apps
Software
$35M27 Jun 2017 Mountain View, California, United States
News
Glooko Raises $30M Series D Financing

– Glooko, a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, has raised a $30m Series D round of funding.
– The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
– Proceeds will be used to accelerate organic growth and strategic initiatives across the company’s broad and growing product line of advanced digital health solutions.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Insulet?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: